Back
Bright Minds Biosciences 10K Form
Buy
59
DRUG
Bright Minds Biosciences
Last Price:
$33.10
Seasonality Move:
10.72%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DRUG News And Ratings
See the #1 stock for the next 7 days that we like better than DRUG
DRUG Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.77 |
| Price / Book: | 5.58 |
Profitability
| EPS (TTM): | -0.17730 |
|---|---|
| Net Income (TTM): | $-789.1K |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Bright Minds Biosciences Earnings Forecast
Key Bright Minds Biosciences Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Bright Minds Biosciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DRUG |
| Website: | brightmindsbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DRUG Technical Analysis vs Fundamental Analysis
Buy
59
Bright Minds Biosciences (DRUG)
is a Buy
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a BuyThe current Bright Minds Biosciences [DRUG] share price is $31.89. The Score for DRUG is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.